Selected article for: "control prevention and International license"

Author: Ying Liu; Yueping Liu; Bo Diao; Feifei Ren; Yue Wang; Jinya Ding; Qianchuan Huang
Title: Diagnostic Indexes of a Rapid IgG/IgM Combined Antibody Test for SARS-CoV-2
  • Document date: 2020_3_30
  • ID: hnetng0w_5
    Snippet: The New Coronavirus Pneumonia Prevention and Control Program (7th edition) published by the National Health Commission of China also recommended that any suspicious cases together with positive IgM/IgG antibodies can be deemed as positive COVID-19 cases. However, data concentrating on its sensitivity, specificity were inadequate, which were of paramount value in the decision whether, when and how to use IgM/IgG antibodies detection. The aim of th.....
    Document: The New Coronavirus Pneumonia Prevention and Control Program (7th edition) published by the National Health Commission of China also recommended that any suspicious cases together with positive IgM/IgG antibodies can be deemed as positive COVID-19 cases. However, data concentrating on its sensitivity, specificity were inadequate, which were of paramount value in the decision whether, when and how to use IgM/IgG antibodies detection. The aim of this study was to evaluate the sensitivity, specificity, accuracy, positive predictive value (PPV), negative predictive value (NPV), especially Kappa efficiency with PCR and its anti-interference ability. CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • antibody detection and IgM IgG antibody: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antibody detection and International license: 1, 2, 3, 4, 5, 6
    • antibody detection and negative predictive value: 1, 2, 3, 4, 5, 6, 7
    • antibody detection and NPV negative predictive value: 1, 2, 3, 4
    • antibody detection and positive case: 1, 2, 3
    • antibody detection and positive IgM IgG antibody: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • antibody detection and positive predictive value: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • antibody detection and PPV positive predictive value: 1, 2, 3
    • antibody detection and predictive value: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • antibody detection and study aim: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • cc NC ND International license and IgM IgG antibody: 1, 2
    • cc NC ND International license and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc NC ND International license and positive case: 1
    • cc NC ND International license and predictive value: 1, 2, 3
    • cc NC ND International license and study aim: 1
    • IgM IgG antibody and International license: 1, 2, 3, 4, 5, 6
    • IgM IgG antibody and Kappa efficiency: 1
    • IgM IgG antibody and negative predictive value: 1, 2, 3, 4, 5, 6, 7
    • IgM IgG antibody and NPV negative predictive value: 1, 2, 3